GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PeptiDream Inc (OTCPK:PPTDF) » Definitions » Margin of Safety % (DCF Dividends Based)

PPTDF (PeptiDream) Margin of Safety % (DCF Dividends Based) : N/A (As of Mar. 22, 2025)


View and export this data going back to 2014. Start your Free Trial

What is PeptiDream Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

As of today (2025-03-22), PeptiDream's Predictability Rank is 4.5-Stars. PeptiDream's intrinsic value calculated from the Discounted Dividend model is $30.58 and current share price is $17.85. Consequently,

PeptiDream's Margin of Safety % (DCF Dividends Based) using Discounted Dividend model is N/A.

Competitive Comparison of PeptiDream's Margin of Safety % (DCF Dividends Based)

For the Biotechnology subindustry, PeptiDream's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PeptiDream's Margin of Safety % (DCF Dividends Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PeptiDream's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where PeptiDream's Margin of Safety % (DCF Dividends Based) falls into.


PeptiDream Margin of Safety % (DCF Dividends Based) Calculation

PeptiDream's Margin of Safety % (DCF Dividends Based) for today is calculated as

Margin of Safety % (DCF Dividends Based)=(Intrinsic Value: DCF (Dividends Based)-Current Price)/Intrinsic Value: DCF (Dividends Based)
=(0.00-17.85)/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Dividend model with default parameters.

PeptiDream Margin of Safety % (DCF Dividends Based) Related Terms

Thank you for viewing the detailed overview of PeptiDream's Margin of Safety % (DCF Dividends Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

PeptiDream Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PeptiDream Inc (OTCPK:PPTDF) » Definitions » Margin of Safety % (DCF Dividends Based)
Comparable Companies
TSE:2160 TSE:4974 TSE:4592 TSE:4565 TSE:4894 TSE:219A TSE:4593 TSE:4575 TSE:4599 TSE:7774 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
4587:Japan
Address
1-2-10, Nihonbashi, Chuo-ku, Toyo Building, 6th Floor, Tokyo, JPN, 103-0027
Website
http://www.peptidream.com
PeptiDream Inc is a biopharmaceutical company, engaged in the research and development of new pharmaceutical candidates. It discovers constrained peptides, small molecules, and peptide-drug conjugate therapeutics using its Peptide Discovery Platform System. The company aspires to be a leader in drug discovery and development to address unmet medical needs and improve the quality of life of patients worldwide.